Cardiovascular disease amounts to 28% of all deaths in UAE

Notes and media contacts

About Pfizer:

Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. The company discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. At Pfizer, nearly 90,000 colleagues in more than 90 countries work every day to help people stay happier, healthier and longer. Worldwide, Pfizer provides treatment for over 38 million patients a day. The company's overarching purpose: Working Together for a Healthier World.

About the TNT Study:

The TNT study was an investigator-led trial coordinated by an independent steering committee and funded by Pfizer. The study enrolled 10,001 men and women with coronary heart disease aged 35 years to 75 years in 14 countries and followed them for an average of five years. Primary study results were published in The New England Journal of Medicine in 2005.

The primary endpoint of the original TNT study was the occurrence of a first major cardiovascular event, defined as death from heart disease, non-fatal heart attacks, resuscitated cardiac arrest, or fatal or non-fatal strokes.

In contrast, the endpoint for this subanalysis was any cardiovascular event, defined as death from heart disease, non-fatal heart attack, resuscitated cardiac arrest, certain types of heart surgery, procedure-related heart attack, chest pain, fatal or non-fatal stroke, peripheral arterial disease or hospitalization due to chronic heart failure.

Lipitor 80 mg is not a starting dose. Lipitor is not approved in all countries to reduce the risk of cardiovascular events in patients with existing heart disease.

For further information, kindly contact:

Lucy Hambour
Account Director
Wallis Marketing Consultants
P.O. Box 502281
Dubai, United Arab Emirates
Tel: +971 4 390 1950
Fax: +971 4 367 2800